JP2011024708A - Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same - Google Patents
Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same Download PDFInfo
- Publication number
- JP2011024708A JP2011024708A JP2009171916A JP2009171916A JP2011024708A JP 2011024708 A JP2011024708 A JP 2011024708A JP 2009171916 A JP2009171916 A JP 2009171916A JP 2009171916 A JP2009171916 A JP 2009171916A JP 2011024708 A JP2011024708 A JP 2011024708A
- Authority
- JP
- Japan
- Prior art keywords
- hollow fiber
- fiber membrane
- blood purification
- spinning
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 216
- 239000012510 hollow fiber Substances 0.000 title claims abstract description 194
- 239000008280 blood Substances 0.000 title claims abstract description 46
- 210000004369 blood Anatomy 0.000 title claims abstract description 46
- 238000000746 purification Methods 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title abstract description 20
- 238000000034 method Methods 0.000 title description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 56
- 235000011187 glycerol Nutrition 0.000 claims abstract description 28
- 239000011148 porous material Substances 0.000 claims abstract description 25
- 230000003746 surface roughness Effects 0.000 claims abstract description 12
- 239000004698 Polyethylene Substances 0.000 claims description 15
- -1 polyethylene Polymers 0.000 claims description 15
- 229920000573 polyethylene Polymers 0.000 claims description 15
- 238000011049 filling Methods 0.000 claims description 9
- 238000009987 spinning Methods 0.000 description 60
- 238000005406 washing Methods 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 238000005345 coagulation Methods 0.000 description 28
- 230000015271 coagulation Effects 0.000 description 28
- 239000000463 material Substances 0.000 description 24
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 23
- 239000000126 substance Substances 0.000 description 18
- 238000004140 cleaning Methods 0.000 description 16
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 229940057995 liquid paraffin Drugs 0.000 description 11
- 230000035699 permeability Effects 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- 229920002284 Cellulose triacetate Polymers 0.000 description 8
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 8
- 239000012298 atmosphere Substances 0.000 description 8
- 238000004804 winding Methods 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 229920002492 poly(sulfone) Polymers 0.000 description 6
- 230000002950 deficient Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000011810 insulating material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004695 Polyether sulfone Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 229920006393 polyether sulfone Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229920001747 Cellulose diacetate Polymers 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000002441 uremic toxin Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Artificial Filaments (AREA)
Abstract
【課題】
モジュール作製時の歩留まりが高い血液浄化用中空糸膜を提供する。
【解決手段】
内径が100〜300μmであり、平均膜厚が10〜50μmであり、細孔内にグリセリンが充填されている血液浄化用中空糸膜であって、該中空糸膜を乾燥状態で原子間力顕微鏡によって測定すると、外表面の平均面粗さ(Ra値)が10nm以下であることを特徴とする。
【選択図】なし【Task】
Provided is a blood purification hollow fiber membrane having a high yield in module production.
[Solution]
A hollow fiber membrane for blood purification having an inner diameter of 100 to 300 μm, an average film thickness of 10 to 50 μm, and pores filled with glycerin, wherein the hollow fiber membrane is dried in an atomic force microscope The average surface roughness (Ra value) of the outer surface is 10 nm or less.
[Selection figure] None
Description
本発明は、モジュールを組み立てる際に、ケースと中空糸膜のすべり性が高いことにより作製歩留まりが良い、血液浄化用中空糸膜およびその製造方法に関する。 The present invention relates to a hollow fiber membrane for blood purification and a method for producing the same, in which, when a module is assembled, the case and the hollow fiber membrane are highly slippery, so that the production yield is good.
腎不全治療などにおける血液浄化法では、血液中の尿毒素、老廃物を除去する目的で、天然素材であるセルロース、その誘導体であるセルロースジアセテート、セルローストリアセテート、合成高分子であるポリスルホン、ポリメチルメタクリレート、ポリアクリロニトリルなどの高分子からなる透析膜や限外濾過膜を分離材として用いた血液浄化器が広く使用されている。特に、中空糸型の膜を分離材として用いた血液浄化用中空糸膜モジュールは、体外循環にかかわる循環血液量の低減、血中の物質除去効率の高さ、さらに血液浄化器組み立ての高い生産性などの利点から血液浄化分野での重要度が高い。 In blood purification methods such as the treatment of renal failure, natural materials such as cellulose, its derivatives cellulose diacetate, cellulose triacetate, synthetic polymers such as polysulfone, and polymethyl are used for the purpose of removing uremic toxins and waste products in the blood. Blood purifiers using dialysis membranes or ultrafiltration membranes made of polymers such as methacrylate and polyacrylonitrile as separation materials are widely used. In particular, a hollow fiber membrane module for blood purification using a hollow fiber membrane as a separation material reduces the amount of circulating blood involved in extracorporeal circulation, high removal efficiency of blood substances, and high production of blood purifier assemblies. It is highly important in the field of blood purification because of its advantages such as sex.
中空糸膜を用いた血液浄化用中空糸膜モジュールは、紡糸された中空糸膜を束状に巻き取り、巻き取った中空糸膜束をモジュールケースに挿入し、次いで、ケースの端部においてウレタンやエポキシなどの樹脂で中空糸膜束とケースを液密に接着し、その後、内孔が開口するように接着部分を切断することによって行われる。 A hollow fiber membrane module for blood purification using a hollow fiber membrane is obtained by winding a spun hollow fiber membrane into a bundle, inserting the wound hollow fiber membrane bundle into a module case, and then urethane at the end of the case. The hollow fiber membrane bundle and the case are liquid-tightly bonded with a resin such as epoxy or epoxy, and then the bonded portion is cut so that the inner hole is opened.
このとき、中空糸膜のすべり性は、モジュール作製時の歩留まりに大きく影響を与える。例えば、巻き取った中空糸膜束をモジュールケースに挿入するときに、ケース内径と中空糸膜束径の差が小さいと、ケース内面と中空糸膜あるいは中空糸膜同士がこすれて糸切れが発生し不良モジュールとなる。 At this time, the slipperiness of the hollow fiber membrane greatly affects the yield during module production. For example, when the wound hollow fiber membrane bundle is inserted into the module case, if the difference between the case inner diameter and the hollow fiber membrane bundle diameter is small, the inner surface of the case and the hollow fiber membrane or the hollow fiber membranes are rubbed and thread breakage occurs. It becomes a defective module.
モジュール作製の歩留まりを向上させるためには、膜形成時のポリマー濃度を高めたり、中空糸膜の膜厚を厚くすることによって、中空糸膜の強度を高める方法が一般的に採用される。しかし血液浄化に用いられる中空糸膜は、血液から有害物質を取り除く目的で使用されるため、物質透過性を高める必要があり、これらの方法は、性能の向上に不利な傾向につながるため、おのずと限界がある。 In order to improve the yield of module production, a method of increasing the strength of the hollow fiber membrane by increasing the polymer concentration at the time of membrane formation or increasing the thickness of the hollow fiber membrane is generally employed. However, since hollow fiber membranes used for blood purification are used for the purpose of removing harmful substances from blood, it is necessary to increase substance permeability, and these methods naturally lead to a disadvantageous tendency to improve performance. There is a limit.
モジュールケースへの膜束の挿入を容易にした対策としては、外表面中心粗さを15nm以上にし、外表面の開孔率を6〜20%に制御する方法が提案されている(特許文献1参照)。この方法は、中空糸膜の外表面が開孔している場合に孔の割合とそれに付随する表面の凹凸を一定条件に制御することによってモジュールケースへの膜束の充填を行い易くしたものである。 As a measure for facilitating the insertion of the film bundle into the module case, a method has been proposed in which the outer surface center roughness is set to 15 nm or more and the outer surface open area ratio is controlled to 6 to 20% (Patent Document 1). reference). This method facilitates the filling of the membrane bundle into the module case by controlling the hole ratio and the accompanying surface irregularities when the outer surface of the hollow fiber membrane is open to constant conditions. is there.
また、物理的指標として、中空糸膜対中空糸膜の静止摩擦係数と動摩擦係数を一定の範囲に制御する方法が提案されている(特許文献2参照)。これらの指標は、化学繊維の測定基準にのっとって測定されるものであり、中空糸膜の物理的特性を評価したものである。 As a physical index, a method of controlling the static friction coefficient and the dynamic friction coefficient of the hollow fiber membrane to the hollow fiber membrane within a certain range has been proposed (see Patent Document 2). These indices are measured according to the measurement standard of chemical fibers, and are an evaluation of the physical characteristics of the hollow fiber membrane.
特許文献1の方法では、外表面が開孔している中空糸膜の場合は、開孔を伴った凹凸の制御でモジュール化におけるケーシングが容易になるが、細孔内にグリセリンが充填されている中空糸膜の場合は、開孔率というパラメータを利用することができない。また、特許文献2の方法は、中空糸膜特有の摩擦係数のみを制御するだけであり、モジュール化ケーシング工程において重要な摩擦係数である膜束とそれに接触するケースとの摩擦係数に関しては何ら考慮されていない。 In the method of Patent Document 1, in the case of a hollow fiber membrane having an open outer surface, the casing in modularization is facilitated by controlling the unevenness accompanied by the opening, but the pores are filled with glycerin. In the case of a hollow fiber membrane, a parameter called a hole area ratio cannot be used. Further, the method of Patent Document 2 only controls the friction coefficient peculiar to the hollow fiber membrane, and no consideration is given to the friction coefficient between the membrane bundle that is an important friction coefficient in the modular casing process and the case that contacts the membrane bundle. It has not been.
一方、産業用の糸の製造においては、油剤を用いて、糸のすべり性を高めることが古くから行われている。しかし、医療用として血液と直接接触する血液浄化用中空糸膜の製造には、安全上の問題から油剤を使用することはできず、本発明者らが知る限り、血液浄化用中空糸膜の糸すべり性を高める目的で油剤を使用する例は従来から存在しない。 On the other hand, in the manufacture of industrial yarns, it has long been practiced to improve the slipperiness of yarns using an oil agent. However, for the production of a hollow fiber membrane for blood purification that is in direct contact with blood for medical use, an oil agent cannot be used for safety reasons. As far as the present inventors know, the hollow fiber membrane for blood purification There has never been an example in which an oil agent is used for the purpose of improving thread slippage.
本発明は、上記の従来技術の現状に鑑み創案されたものであり、その目的は、束状に巻き取られた中空糸膜束をモジュールケースに挿入する際の中空糸膜とモジュールケース内面とのこすれによる糸切れを防止した、すべり性の高い血液浄化用中空糸膜およびその製造方法を提供することにある。 The present invention was devised in view of the above-described state of the prior art, and its purpose is to apply a hollow fiber membrane and an inner surface of the module case when the bundle of hollow fiber membranes wound in a bundle is inserted into the module case. An object of the present invention is to provide a highly slippery hollow fiber membrane for blood purification that prevents thread breakage due to slipping, and a method for producing the same.
本発明者らは、上記目的を達成するために鋭意検討した結果、細孔内にグリセリンが充填されている中空糸膜において、原子間力顕微鏡の測定による中空糸膜外表面の乾燥状態における平均面粗さ(Ra値)を小さくすることにより、中空糸膜モジュール組み立ての際に、中空糸膜とモジュールケース内面とのこすれによる中空糸膜の折れなどのダメージが無くなり、作製歩留まりを向上させることができることを見出し、本発明の完成に至った。 As a result of intensive studies to achieve the above object, the inventors of the present invention, as a result, in the hollow fiber membrane filled with glycerin in the pores, the average in the dry state of the outer surface of the hollow fiber membrane as measured by an atomic force microscope By reducing the surface roughness (Ra value), the hollow fiber membrane module can be assembled without any damage such as breakage of the hollow fiber membrane due to rubbing between the hollow fiber membrane and the inner surface of the module case, thereby improving the production yield. As a result, the present invention has been completed.
すなわち、本発明は、以下の構成を有するものである。
(1)内径が100〜300μmであり、平均膜厚が10〜50μmであり、細孔内にグリセリンが充填されている血液浄化用中空糸膜であって、該中空糸膜を乾燥状態で原子間力顕微鏡によって測定すると、外表面の平均面粗さ(Ra値)が10nm以下であることを特徴とする血液浄化用中空糸膜。
(2)ポリエチレン製パイプ内に充填率47%で充填された中空糸膜束を、ポリエチレン製パイプから押し出そうとする時にかかる荷重が、20N以下であることを特徴とする(1)に記載の血液浄化用中空糸膜。
(3)(1)または(2)に記載の血液浄化用中空糸膜を組み込んだことを特徴とする血液浄化用中空糸膜モジュール。
That is, the present invention has the following configuration.
(1) A blood purification hollow fiber membrane having an inner diameter of 100 to 300 μm, an average film thickness of 10 to 50 μm, and pores filled with glycerin, wherein the hollow fiber membrane is atomized in a dry state A hollow fiber membrane for blood purification, wherein the average surface roughness (Ra value) of the outer surface is 10 nm or less as measured by an atomic force microscope.
(2) The load applied when the hollow fiber membrane bundle filled in the polyethylene pipe at a filling rate of 47% is pushed out from the polyethylene pipe is 20 N or less. (1) Hollow fiber membrane for blood purification.
(3) A blood purification hollow fiber membrane module comprising the blood purification hollow fiber membrane according to (1) or (2).
本発明の中空糸膜は、細孔内にグリセリンを充填して外表面が開孔されていない中空糸膜の外表面の平均面粗さを小さくしているので、中空糸膜外表面の糸すべり性がよい。従って、この中空糸膜を束状に巻き取り、これをモジュールケースに挿入したときに、中空糸膜同士のこすれによる糸切れがほとんどないため、不良モジュールがなく、血液浄化中空糸膜モジュールの生産性が高い。 In the hollow fiber membrane of the present invention, since the average surface roughness of the outer surface of the hollow fiber membrane in which pores are filled with glycerin and the outer surface is not opened is reduced, the yarn on the outer surface of the hollow fiber membrane Good slip. Therefore, when this hollow fiber membrane is wound into a bundle and inserted into a module case, there is almost no thread breakage due to rubbing between the hollow fiber membranes, so there is no defective module, and production of a blood purification hollow fiber membrane module High nature.
以下、本発明の血液浄化用中空糸膜を詳細に説明する。 Hereinafter, the hollow fiber membrane for blood purification of the present invention will be described in detail.
本発明の血液浄化用中空糸膜は、細孔内にグリセリンが充填されたものであり、中空糸膜を乾燥状態で原子間力顕微鏡によって測定すると、外表面の平均面粗さ(Ra値)が10nm以下であることを特徴とする。 The hollow fiber membrane for blood purification of the present invention is one in which pores are filled with glycerin. When the hollow fiber membrane is measured by an atomic force microscope in a dry state, the average surface roughness (Ra value) of the outer surface. Is 10 nm or less.
本発明者は、細孔内にグリセリンが充填された中空糸膜において、中空糸膜とモジュールケース内面とのこすれ、すなわち、すべり性が、中空糸膜の外表面の平滑性に関係していると考え、中空糸膜の外表面の平滑性がすべり性に及ぼす影響について調査した結果、中空糸外表面の平滑性が低い場合にすべり性が悪くなることを見出した。 In the hollow fiber membrane in which the pores are filled with glycerin, the inventor rubs the hollow fiber membrane and the inner surface of the module case, that is, the slipperiness is related to the smoothness of the outer surface of the hollow fiber membrane. As a result of investigating the influence of the smoothness of the outer surface of the hollow fiber membrane on the slipperiness, it was found that the slipperiness deteriorates when the smoothness of the outer surface of the hollow fiber is low.
すべり性を評価する方法としては、ポリエチレン製パイプ内に一定の充填率で充填された中空糸膜束を、ポリエチレン製パイプから押し出そうとする時にかかる荷重の測定を行った。この荷重が小さいほど、中空糸膜のすべり性が良く、中空糸膜外表面の平滑性が高いと考えられる。 As a method for evaluating the slipping property, a load applied when a hollow fiber membrane bundle filled in a polyethylene pipe at a constant filling rate was to be pushed out from the polyethylene pipe was measured. It is considered that the smaller the load, the better the slip property of the hollow fiber membrane and the higher the smoothness of the outer surface of the hollow fiber membrane.
本発明の中空糸膜は、ポリエチレン製パイプ内に充填率47%で充填された中空糸膜束を、ポリエチレン製パイプから押し出そうとする時にかかる荷重が20N以下であることが好ましい。より好ましくは15N以下である。荷重がかかる範囲であれば、中空糸膜とモジュールケース内面とのこすれが小さく、中空糸膜に対してダメージを与えることが少ない。一方、かかる範囲を超えると、中空糸膜束の外側の中空糸とポリエチレン製パイプとが強くこすれて、糸切れ、糸折れになり易い。 In the hollow fiber membrane of the present invention, it is preferable that a load applied when a hollow fiber membrane bundle filled in a polyethylene pipe at a filling rate of 47% is pushed out of the polyethylene pipe is 20 N or less. More preferably, it is 15 N or less. When the load is applied, the rubbing between the hollow fiber membrane and the inner surface of the module case is small, and the hollow fiber membrane is hardly damaged. On the other hand, if this range is exceeded, the hollow fiber outside the hollow fiber membrane bundle and the polyethylene pipe are strongly rubbed, and the yarn is likely to break or break.
また、本発明者は、ポリエチレン製パイプ内に充填された中空糸膜束を、ポリエチレン製パイプから押し出そうとする時の荷重が小さい中空糸膜は、その中空糸膜の外表面の平均面粗さ(Ra値)が小さく、外表面が平滑であることを見出した。外表面の平滑性が高い場合には、粘性の高いグリセリンが外表面に余剰に付くことがなく、摩擦係数が小さくなり、すべり性がよくなると考えられる。かかる観点から、本発明の中空糸膜の外表面の平均面粗さ(Ra値)は、中空糸膜を乾燥状態で原子間力顕微鏡によって測定した場合、10nm以下であることが必要であり、さらには9nm以下であることが好ましい。Ra値がかかる範囲を超える場合には、中空糸膜束の外側の中空糸とポリエチレン製パイプとが強くこすれて、糸切れ、糸折れになり易い。Ra値の下限値は、達成容易性の点で現実的には0.1nmである。 In addition, the present inventor, the hollow fiber membrane with a small load when trying to push out the hollow fiber membrane bundle filled in the polyethylene pipe from the polyethylene pipe, the average surface of the outer surface of the hollow fiber membrane It was found that the roughness (Ra value) was small and the outer surface was smooth. When the smoothness of the outer surface is high, it is considered that the highly viscous glycerin is not excessively attached to the outer surface, the friction coefficient is reduced, and the slipping property is improved. From such a viewpoint, the average surface roughness (Ra value) of the outer surface of the hollow fiber membrane of the present invention needs to be 10 nm or less when the hollow fiber membrane is measured by an atomic force microscope in a dry state, Furthermore, it is preferable that it is 9 nm or less. When the Ra value exceeds this range, the hollow fiber outside the hollow fiber membrane bundle and the polyethylene pipe are strongly rubbed, and the yarn tends to break or break. The lower limit of the Ra value is practically 0.1 nm in terms of ease of achievement.
中空糸膜の外表面の平均面粗さ(Ra値)は、後述するように、紡糸原液をノズルから吐出させる際の温度(ノズル温度)と、吐出してから次の凝固工程の凝固浴に浸漬する直前の温度(空中走行部温度)との差、すなわち空中走行部分での温度差を制御したり、水洗工程において中空糸膜と洗浄液とを同一方向に走行させて洗浄したり、工程中の中空糸膜にかかる張力をできるだけ少なくしたりすることなどにより、上記の低い値に抑えることができる。 As will be described later, the average surface roughness (Ra value) of the outer surface of the hollow fiber membrane is determined by the temperature at which the spinning dope is discharged from the nozzle (nozzle temperature) and the coagulation bath in the next coagulation step after the discharge. Controls the difference from the temperature immediately before immersion (air travel part temperature), that is, the temperature difference in the air travel part, or the hollow fiber membrane and the cleaning liquid are run in the same direction in the water washing process and are washed. By reducing the tension applied to the hollow fiber membrane as much as possible, it can be suppressed to the above low value.
本発明の中空糸膜の内径は、100〜300μmであることが必要である。内径が小さすぎると、中空糸膜の中空部を流れる流体の圧力損失が大きくなるため、溶血の恐れがある。また、内径が大きすぎると、中空糸膜の中空部を流れる血液のせん断速度が小さくなるため、血液中のタンパク質が経時的に膜の内面に堆積しやすくなる。中空糸膜内部を流れる血液の圧力損失やせん断速度が適度な範囲となる内径は、特に150〜250μmである。 The inner diameter of the hollow fiber membrane of the present invention needs to be 100 to 300 μm. If the inner diameter is too small, the pressure loss of the fluid flowing through the hollow portion of the hollow fiber membrane increases, which may cause hemolysis. On the other hand, if the inner diameter is too large, the shear rate of blood flowing through the hollow portion of the hollow fiber membrane becomes small, so that proteins in the blood easily accumulate on the inner surface of the membrane over time. The inner diameter at which the pressure loss and shear rate of the blood flowing through the hollow fiber membrane are in an appropriate range is particularly 150 to 250 μm.
また、本発明の中空糸膜の平均膜厚は、10〜50μmであることが必要である。平均膜厚が大きすぎると、透水性は高くても、中〜高分子量物質の透過性が不足することがある。また、血液浄化器の設計上、膜面積を大きくする際に膜厚が大きいと、血液浄化器の大きさが大きくなってしまい適切ではない。膜厚は薄い方が物質透過性が高まるため好ましく、45μm以下が好ましく、40μm以下がより好ましい。但し、平均膜厚が薄すぎると、血液浄化器に必要な最低限の膜強度を維持するのが困難になることがある。したがって、平均膜厚は12μm以上が好ましく、14μm以上がより好ましい。ここでいう平均膜厚とは、ランダムにサンプリングした中空糸膜5本を測定したときの平均値である。この時、それぞれの値と平均値との差が、平均値の2割を超えないこととする。 Moreover, the average film thickness of the hollow fiber membrane of this invention needs to be 10-50 micrometers. When the average film thickness is too large, the permeability of the medium to high molecular weight substance may be insufficient even if the water permeability is high. In addition, in the design of the blood purifier, if the film thickness is large when the membrane area is increased, the size of the blood purifier increases, which is not appropriate. A thinner film thickness is preferred because the material permeability is increased, preferably 45 μm or less, and more preferably 40 μm or less. However, if the average film thickness is too thin, it may be difficult to maintain the minimum film strength necessary for the blood purifier. Therefore, the average film thickness is preferably 12 μm or more, and more preferably 14 μm or more. An average film thickness here is an average value when five hollow fiber membranes sampled at random are measured. At this time, the difference between each value and the average value does not exceed 20% of the average value.
本発明における中空糸膜の素材としては、再生セルロース、セルロースアセテート、セルローストリアセテートなどのセルロース系高分子、ポリスルホンやポリエーテルスルホンなどのポリスルホン系高分子、ポリアクリロニトリル、ポリメチルメタクリレート、エチレンビニルアルコール共重合体などが挙げられるが、高い透水性の中空糸膜を得ることが容易なセルロース系やポリスルホン系が好ましい。特にセルロース系ではセルロースジアセテートやセルローストリアセテート、ポリスルホン系ではポリスルホン、ポリエーテルスルホンが膜厚を薄くすることが容易なため好ましい。 Examples of the material of the hollow fiber membrane in the present invention include cellulose polymers such as regenerated cellulose, cellulose acetate and cellulose triacetate, polysulfone polymers such as polysulfone and polyethersulfone, polyacrylonitrile, polymethyl methacrylate, ethylene vinyl alcohol copolymer Although a coalescence etc. are mentioned, the cellulose type and polysulfone type | system | group which are easy to obtain a highly water-permeable hollow fiber membrane are preferable. In particular, cellulose diacetate or cellulose triacetate is preferable for cellulose, and polysulfone or polyethersulfone is preferable for polysulfone because it is easy to reduce the film thickness.
本発明の中空糸膜は、後述するような方法によって、内表面に緻密層を有し、これに続いて実質的にボイドがない支持層、さらにこれに続いて細孔径が緻密層より大きく、支持層より小さい外表面層を有する不均一な構造を採る。これによって、高い透水性を達成しながら中空糸膜の強度を向上させることができる。 The hollow fiber membrane of the present invention has a dense layer on the inner surface by a method as described later, followed by a support layer substantially free of voids, and subsequently a pore diameter larger than the dense layer, A non-uniform structure having an outer surface layer smaller than the support layer is taken. Thereby, the strength of the hollow fiber membrane can be improved while achieving high water permeability.
次に、本発明の中空糸膜の製造方法について説明する。150〜1000ml/m2/hr/mmHgの高い透水性の中空糸膜を得るためには、紡糸溶液のポリマー濃度は、ポリマーの種類などにもよるが、26質量%以下、より好ましくは25質量%以下とすることが好ましい。紡糸溶液は、紡糸溶液中の不溶成分やゲルを取り除く目的でノズル吐出直前にフィルターにかけることが好ましい。フィルターの孔径は小さい方がよく、具体的には中空糸膜の膜厚以下のものが好ましく、中空糸膜の膜厚の1/2以下がより好ましい。フィルターが無い場合やフィルターの孔径が中空糸膜の膜厚を超える場合、ノズルスリットの一部に詰まりが生じ、偏肉糸の発生を招くことがある。さらに、フィルター無しやフィルター孔径が中空糸膜の膜厚を超えると、紡糸溶液中の不溶解成分やゲルなどの混入が原因で部分的なボイドや、数十μm単位での表面構造のきめの細かさが乱れる(ひきつれたり、部分的にシワがよるなどの)原因となりやすい。高い空孔率を有する中空糸膜において、部分的なボイドの発生は、膜の物理的強度を低下させる原因になり得る。紡糸原液の濾過は、吐出するまでの間に複数回実施してもよく、これによりフィルターの寿命を延ばすことができる。 Next, the manufacturing method of the hollow fiber membrane of this invention is demonstrated. In order to obtain a highly water-permeable hollow fiber membrane of 150 to 1000 ml / m 2 / hr / mmHg, the polymer concentration of the spinning solution depends on the type of polymer, but is 26% by mass or less, more preferably 25% by mass. % Or less is preferable. The spinning solution is preferably applied to a filter immediately before nozzle discharge for the purpose of removing insoluble components and gel in the spinning solution. The pore diameter of the filter is preferably small. Specifically, the pore diameter is preferably not more than the thickness of the hollow fiber membrane, and more preferably not more than 1/2 of the thickness of the hollow fiber membrane. When there is no filter or when the pore diameter of the filter exceeds the film thickness of the hollow fiber membrane, a part of the nozzle slit may be clogged, resulting in occurrence of uneven thickness yarn. Furthermore, if there is no filter or the filter pore size exceeds the film thickness of the hollow fiber membrane, partial voids due to the insoluble components in the spinning solution or the inclusion of gel, etc., and the texture of the surface structure in units of several tens of μm It tends to cause fineness (such as pulling or partial wrinkling). In hollow fiber membranes having a high porosity, the generation of partial voids can cause a reduction in the physical strength of the membrane. Filtration of the spinning dope may be carried out a plurality of times before discharging, thereby extending the life of the filter.
上記のように処理した紡糸原液を、外側に環状部、内側に中空形成材吐出孔を有するチューブインオリフィス型ノズルを用いて吐出する。ノズルのスリット幅(紡糸原液を吐出する環状部の幅)のばらつきを小さくすることで、紡糸された中空糸膜の偏肉を減らすことができる。具体的には、ノズルのスリット幅の最大値と最小値の差を10μm以下にすることが好ましい。ノズルのスリット幅は、用いる紡糸原液の粘度や、得られる中空糸膜の膜厚、中空形成材の種類によって異なるが、このばらつきが大きいと、偏肉を招き、肉厚の薄い部分が裂けたり破裂したりしてリークの原因になる。また、偏肉が顕著である場合、血液浄化膜として適切な強度が得られない原因となる。 The spinning dope treated as described above is discharged using a tube-in-orifice type nozzle having an annular portion on the outside and a hollow forming material discharge hole on the inside. By reducing the variation in the slit width of the nozzle (the width of the annular portion that discharges the spinning dope), uneven thickness of the spun hollow fiber membrane can be reduced. Specifically, the difference between the maximum value and the minimum value of the slit width of the nozzle is preferably 10 μm or less. The slit width of the nozzle varies depending on the viscosity of the spinning dope used, the thickness of the hollow fiber membrane to be obtained, and the type of the hollow forming material. If this variation is large, uneven thickness may be caused, and the thin portion may be torn. Rupture and cause leaks. Moreover, when uneven thickness is remarkable, it becomes a cause by which appropriate intensity | strength as a blood purification film cannot be obtained.
紡糸原液を吐出する際のノズルの温度は、次工程の凝固浴に入るまでの空中走行部分における効果を十分に得るために、一般的な中空糸膜製造条件より低い温度にすることが好ましい。具体的には、紡糸原液のノズル吐出温度は、50℃〜130℃であることが好ましく、55℃〜125℃以下がより好ましい。ノズル吐出温度が低すぎると、ドープの粘度が高くなるため、ノズルにかかる圧力が高くなり紡糸原液を安定に吐出できないことがある。また、ノズル温度が高すぎると、相分離による膜構成に影響し孔径が大きくなりすぎる可能性がある。 The temperature of the nozzle when discharging the spinning dope is preferably set to a temperature lower than the general hollow fiber membrane production conditions in order to sufficiently obtain the effect in the aerial traveling portion until entering the coagulation bath in the next step. Specifically, the nozzle discharge temperature of the spinning dope is preferably 50 ° C to 130 ° C, and more preferably 55 ° C to 125 ° C. When the nozzle discharge temperature is too low, the viscosity of the dope increases, so that the pressure applied to the nozzle increases and the spinning dope may not be discharged stably. On the other hand, if the nozzle temperature is too high, there is a possibility that the pore size becomes too large due to the influence of the phase separation on the membrane structure.
吐出した紡糸原液は、空中走行部を経て凝固浴に浸漬される。この時の空中走行部は、外気と遮断する部材(紡糸管)で囲み、紡糸原液の吐出温度(ノズル温度)と凝固浴浸漬直前温度(空中走行部温度)の温度差を60〜120℃、特に95〜120℃になるようにすることが好ましい。凝固浴浸漬直前温度とは、紡糸管内において凝固浴液面よりおよそ1cm程度の高さの位置で測定した温度を指し、空中走行部温度と実質的に同じである。具体的には、凝固浴浸漬直前温度は、実測で15℃以下にすることが好ましく、さらには10℃以下、特に5℃以下にすることが好ましい。空中走行部をこのように低温に制御する方法としては、紡糸管に冷媒を循環させる方法や冷却した風を流し込む方法などが挙げられる。冷媒の冷却や風の冷却は液体窒素やドライアイスなどを用いて制御することが可能であるが、作業性を考慮した場合、空中走行部の温度は−20℃以上であることが好ましい。また、空中走行部の雰囲気は、紡糸原液の相分離に影響を与えるため均一に保たれることが望ましく、囲いなどで覆うことにより温度や風速にムラが生じないようにすることが好ましい。空中走行部の雰囲気、温度、風速にムラがあると、ミクロな膜構造にばらつきができる原因となり、性能発現に問題が生じるため適切でない。 The discharged spinning solution is immersed in the coagulation bath through the aerial traveling section. At this time, the air travel section is surrounded by a member (spinning tube) that shuts off the outside air, and the temperature difference between the discharge temperature of the spinning stock solution (nozzle temperature) and the temperature immediately before the coagulation bath immersion (air travel section temperature) is 60 to 120 ° C., It is particularly preferable that the temperature is 95 to 120 ° C. The temperature immediately before immersion in the coagulation bath refers to a temperature measured at a height of about 1 cm from the surface of the coagulation bath in the spinning tube, and is substantially the same as the air travel temperature. Specifically, the temperature immediately before immersion in the coagulation bath is preferably 15 ° C. or less, more preferably 10 ° C. or less, and particularly preferably 5 ° C. or less. Examples of the method for controlling the air travel unit at such a low temperature include a method of circulating a refrigerant through the spinning tube and a method of flowing cooled air. The cooling of the refrigerant and the cooling of the wind can be controlled using liquid nitrogen, dry ice, or the like. However, in consideration of workability, the temperature of the aerial traveling section is preferably −20 ° C. or higher. In addition, the atmosphere in the aerial traveling section is desirably kept uniform because it affects the phase separation of the spinning dope, and it is preferable to prevent the temperature and wind speed from becoming uneven by covering with an enclosure or the like. Unevenness in the atmosphere, temperature, and wind speed of the aerial traveling section is not appropriate because it causes variations in the microscopic film structure and causes problems in performance.
空中走行部分の温度や風速にムラが生じないようにする方法としては、空中走行部の囲いに適度な大きさの穴をあけ、冷却した風が均一に流れるようにする方法が挙げられる。空中走行部の囲いにあける穴の数は特に限定されないが、紡糸される中空糸膜が揺れない程度に、全体に風が行き渡る状態になるよう調節することが重要である。また、ノズル出口部分を急激に冷却すると、ノズル出口付近でゲルが形成され易くなり、ノズルが閉塞したりして、中空糸膜の偏肉度が高くなることがある。このような現象を回避するためには、ノズルブロックと空中走行部の囲いとの間に断熱材を入れるのも有効な手段となり得る。断熱材の種類は、熱伝導を遮断できるものであれば特に限定されず、セラミックスやプラスチックなどが利用できる。 As a method for preventing unevenness in the temperature and wind speed of the aerial traveling part, there is a method of making a hole of an appropriate size in the enclosure of the aerial traveling part so that the cooled wind flows uniformly. The number of holes in the enclosure of the aerial traveling unit is not particularly limited, but it is important to adjust so that the wind is spread over the whole so that the hollow fiber membrane to be spun does not shake. Further, when the nozzle outlet portion is rapidly cooled, gel is likely to be formed in the vicinity of the nozzle outlet, the nozzle may be blocked, and the thickness of the hollow fiber membrane may be increased. In order to avoid such a phenomenon, it can be an effective means to insert a heat insulating material between the nozzle block and the enclosure of the aerial traveling unit. The type of the heat insulating material is not particularly limited as long as it can block heat conduction, and ceramics, plastics, and the like can be used.
断熱材の厚さは、5〜20mmであることが好ましい。断熱材の厚みが薄すぎると、熱の遮断が充分でなく、ノズルの断熱効果が十分でないことがある。また、断熱材の厚みが厚すぎると、空中走行部での冷却の効果が中空糸膜形成に反映されない可能性がある。この方法により、ノズルから吐出された直後のドープがノズル出口部分を閉塞する可能性は低下し、真円度の高い中空糸膜を安定に紡糸できるようになる。ノズル温度を適度に低くし、空中走行部の温度を低く保つことで、製膜工程におけるゲル化速度を一定に制御することができる。また、空中走行部を通常より低温に設定することによって、中空糸膜外表面で急激なゲル化が促進されるため、膜の断面構造は中空糸膜の内面、外面がそれぞれ中間部と比較して密な層を有する三層構造を形成することができる。このような三層構造をとることは、中空糸膜の強度を向上させるうえで有効である。 The thickness of the heat insulating material is preferably 5 to 20 mm. If the thickness of the heat insulating material is too thin, the heat is not sufficiently blocked, and the heat insulating effect of the nozzle may not be sufficient. Moreover, when the thickness of a heat insulating material is too thick, there exists a possibility that the effect of the cooling in an aerial travel part may not be reflected in hollow fiber membrane formation. By this method, the possibility that the dope immediately after being discharged from the nozzle closes the nozzle outlet portion is reduced, and a hollow fiber membrane having a high roundness can be stably spun. By making the nozzle temperature appropriately low and keeping the temperature of the aerial traveling part low, the gelation rate in the film forming process can be controlled to be constant. In addition, by setting the aerial running part at a lower temperature than usual, rapid gelation is promoted on the outer surface of the hollow fiber membrane, so the cross-sectional structure of the membrane is compared with the inner part and outer part of the hollow fiber membrane, respectively. A three-layer structure with dense layers can be formed. Taking such a three-layer structure is effective in improving the strength of the hollow fiber membrane.
中空形成材は、使用する紡糸原液にもよるが、不活性な液体や気体を用いることが好ましい。このような中空形成材の具体例としては、流動パラフィンやミリスチン酸イソプロピル、窒素、アルゴンなどが挙げられる。また、中空糸膜の内表面に緻密層を形成するためには、紡糸原液の調製に用いた溶媒の水溶液や水などを用いることができる。これらの中空形成材には、必要に応じてグリセリン、エチレングリコール、トリエチレングリコール、ポリエチレングリコールなどの非溶媒または水などを加えることもできる。 The hollow forming material is preferably an inert liquid or gas, although it depends on the spinning dope used. Specific examples of such a hollow forming material include liquid paraffin, isopropyl myristate, nitrogen, argon, and the like. Further, in order to form a dense layer on the inner surface of the hollow fiber membrane, an aqueous solution of solvent used in the preparation of the spinning dope, water or the like can be used. Non-solvents such as glycerin, ethylene glycol, triethylene glycol, and polyethylene glycol, or water can be added to these hollow forming materials as necessary.
空中走行部を経て、ゲル化した膜は、凝固浴中を通過させることにより凝固される。凝固浴は、紡糸原液を調製する際に使用した溶媒の水溶液からなることが好ましい。凝固浴が水である場合には、ゲル化した膜が急激に凝固し、中空糸膜外表面に緻密な層が形成される。急激に凝固した膜の表面は、開孔しない反面、表面粗さの制御が困難である。この場合、凝固浴を溶媒と水との混合液にすることで、凝固時間の制御や中空糸膜の表面粗さを適度に調節しやすくすることができる。凝固浴の溶媒濃度は、70質量%以下であることが好ましく、50質量%以下がより好ましい。ただし、溶媒濃度が1質量%未満では、紡糸時の濃度制御が困難であるため、溶媒濃度の下限は1質量%以上が好ましい。凝固浴の温度は、凝固速度の制御のため4〜50℃であることが好ましい。より好ましくは10〜45℃である。このように空中走行部と凝固浴で緩やかに中空糸膜を形成することで、細孔の大きさや分布、細孔数が適度な中空糸膜が得られる。凝固浴には、必要に応じてグリセリンやエチレングリコール、トリエチレングリコール、ポリエチレングリコールなどの非溶媒、また酸化防止剤や潤滑剤などの添加剤を加えることもできる。 The gelled film is solidified by passing through the coagulation bath through the air running part. The coagulation bath is preferably composed of an aqueous solution of the solvent used when preparing the spinning dope. When the coagulation bath is water, the gelled membrane rapidly solidifies, and a dense layer is formed on the outer surface of the hollow fiber membrane. The surface of the rapidly solidified film does not open, but it is difficult to control the surface roughness. In this case, by making the coagulation bath a mixed solution of a solvent and water, the control of the coagulation time and the surface roughness of the hollow fiber membrane can be easily adjusted appropriately. The solvent concentration of the coagulation bath is preferably 70% by mass or less, and more preferably 50% by mass or less. However, if the solvent concentration is less than 1% by mass, it is difficult to control the concentration during spinning, so the lower limit of the solvent concentration is preferably 1% by mass or more. The temperature of the coagulation bath is preferably 4 to 50 ° C. for controlling the coagulation rate. More preferably, it is 10-45 degreeC. Thus, a hollow fiber membrane having a moderate size, distribution, and number of pores can be obtained by gently forming the hollow fiber membrane with the air running portion and the coagulation bath. A non-solvent such as glycerin, ethylene glycol, triethylene glycol, or polyethylene glycol, or an additive such as an antioxidant or a lubricant can be added to the coagulation bath as necessary.
凝固浴を経た中空糸膜は、洗浄工程を経て溶媒などの不要な成分を洗い流される。このときに用いる洗浄液は、水が好ましく、その温度は洗浄効果の点で20℃〜80℃が好ましい。20℃未満では洗浄効率が悪く、80℃超では熱効率が悪いことと、中空糸膜への負担が大きく、保存安定性や性能に影響を与えることがある。また、膜は凝固浴工程後も活きており、洗浄浴中で外部から力を加えると膜構造や表面形状、孔形状が変形してしまうことがあるので、洗浄浴を走行する中空糸膜になるべく抵抗がかからないようにすることが好ましい。中空糸膜から溶媒や添加剤等の不要な成分を除去するためには、液更新を高めるのが好ましく、従来は、例えば洗浄液のシャワーの中を中空糸膜を走行させたり、洗浄液の流れと中空糸膜の走行を向流にするなどして洗浄効率を高めていた。しかし、このような洗浄方法を採用すると中空糸膜の走行抵抗が大きくなるため、中空糸膜がひきつれたりゆがんだりすることを防ぐ必要があった。 The hollow fiber membrane that has passed through the coagulation bath is washed away of unnecessary components such as a solvent through a washing step. The cleaning liquid used at this time is preferably water, and the temperature is preferably 20 ° C. to 80 ° C. in terms of the cleaning effect. If it is less than 20 ° C, the cleaning efficiency is poor, and if it exceeds 80 ° C, the thermal efficiency is poor, and the burden on the hollow fiber membrane is large, which may affect the storage stability and performance. In addition, the membrane is still active after the coagulation bath process, and if a force is applied from the outside in the washing bath, the membrane structure, surface shape and pore shape may be deformed. It is preferable to prevent resistance as much as possible. In order to remove unnecessary components such as solvents and additives from the hollow fiber membrane, it is preferable to increase the renewal of the liquid. Conventionally, for example, the hollow fiber membrane is run in the shower of the cleaning liquid, the flow of the cleaning liquid Cleaning efficiency was improved by making the running of the hollow fiber membrane counter-current. However, when such a cleaning method is adopted, the running resistance of the hollow fiber membrane is increased, so that it is necessary to prevent the hollow fiber membrane from being pulled or distorted.
本発明者は、中空糸膜の変形抑制と洗浄性の両立を図るため鋭意検討した結果、洗浄液と中空糸膜を同一方向に並流で流すことが有効であることを見出した。洗浄工程の具体的な態様としては、例えば、洗浄浴に傾きをつけ中空糸膜がその傾斜を下っていくような設備が挙げられる。この場合の浴の傾斜は1〜3度が好ましい。3度を超えると、洗浄液の流速が早くなりすぎ中空糸膜の走行抵抗を抑えることができないことがある。1度未満では、洗浄液の滞留による中空糸膜の洗浄不良が発生することがある。このように洗浄浴での中空糸膜への抵抗を抑制することで、洗浄浴入り口の中空糸膜の走行速度と出口の走行速度をほぼ同じにすることができる。また、洗浄効率をより高めるために、洗浄浴は多段に配置されることが好ましい。段数は、洗浄性との兼合いにより適宜設定する必要があり、例えば、本発明に使用される溶媒、非溶媒、親水化剤等の除去を目的とするのであれば、3〜30段程度あれば足りるといえる。 The present inventor has intensively studied to achieve both suppression of deformation of the hollow fiber membrane and cleanability, and as a result, has found that it is effective to flow the cleaning liquid and the hollow fiber membrane in the same direction in parallel flow. As a specific aspect of the washing step, for example, there is an equipment in which the washing bath is inclined and the hollow fiber membrane is lowered. In this case, the inclination of the bath is preferably 1 to 3 degrees. If it exceeds 3 degrees, the flow rate of the cleaning liquid becomes too fast, and the running resistance of the hollow fiber membrane may not be suppressed. If it is less than 1 degree, the cleaning failure of the hollow fiber membrane may occur due to the retention of the cleaning liquid. Thus, by suppressing the resistance to the hollow fiber membrane in the cleaning bath, the traveling speed of the hollow fiber membrane at the inlet of the cleaning bath and the traveling speed of the outlet can be made substantially the same. In order to further increase the cleaning efficiency, the cleaning bath is preferably arranged in multiple stages. The number of stages needs to be set as appropriate depending on the balance with detergency. For example, if the purpose is to remove the solvent, non-solvent, hydrophilizing agent, etc. used in the present invention, there should be about 3 to 30 stages. That's enough.
洗浄工程を経た中空糸膜はグリセリン処理を行なうことが必要である。例えば、セルロース系高分子からなる中空糸膜の場合は中空糸膜をグリセリン浴に通過させた後、乾燥工程を経て巻き取る。この場合、グリセリン濃度は30〜80質量%であることが好ましい。グリセリン濃度が低すぎると、乾燥時に中空糸膜が縮み易く、保存安定性が悪くなることがある。また、グリセリン濃度が高すぎると、中空糸膜に余分なグリセリンが付着しやすく、血液浄化器に組み立てる時に中空糸膜端部の接着性が悪くなることがある。グリセリン浴の温度は40〜80℃であることが好ましい。グリセリン浴の温度が低すぎると、グリセリン水溶液の粘度が高く、中空糸膜の細孔の隅々までグリセリン水溶液が行き渡らない可能性がある。グリセリン浴の温度が高すぎると、中空糸膜が熱で変性、変質してしまう可能性がある。 The hollow fiber membrane that has undergone the washing step needs to be treated with glycerin. For example, in the case of a hollow fiber membrane made of a cellulosic polymer, the hollow fiber membrane is passed through a glycerin bath and then wound through a drying step. In this case, the glycerin concentration is preferably 30 to 80% by mass. If the glycerin concentration is too low, the hollow fiber membrane tends to shrink during drying, and storage stability may deteriorate. Also, if the glycerin concentration is too high, excess glycerin tends to adhere to the hollow fiber membrane, and the adhesiveness at the end of the hollow fiber membrane may deteriorate when assembled into a blood purifier. The temperature of the glycerin bath is preferably 40 to 80 ° C. When the temperature of the glycerin bath is too low, the viscosity of the glycerin aqueous solution is high, and there is a possibility that the glycerin aqueous solution does not reach all the pores of the hollow fiber membrane. If the temperature of the glycerin bath is too high, the hollow fiber membrane may be denatured and altered by heat.
紡糸工程全般において、中空糸膜にかかる張力は膜の構造に影響を及ぼすため、膜構造を変化させないために、極力延伸しないことが好ましい。膜は凝固浴工程後も活きており、洗浄浴中で外部からの力をかけると膜構造や表面構造、孔形状が変形してしまうからである。特に延伸は膜の細孔の形状を真円から楕円に変形させてしまうことから、透過性能への影響も大きいため、低い方が好ましい。具体的には、中空糸膜の凝固浴出口の走行速度と、紡糸工程最後の巻き取り速度との比は、1以上1.2未満であることが好ましい。 In the spinning process as a whole, the tension applied to the hollow fiber membrane affects the structure of the membrane. Therefore, it is preferable not to stretch as much as possible in order not to change the membrane structure. This is because the membrane is still active after the coagulation bath process, and when an external force is applied in the washing bath, the membrane structure, surface structure and pore shape are deformed. In particular, the stretching causes the pore shape of the membrane to be deformed from a perfect circle to an ellipse, and therefore has a great influence on the permeation performance. Specifically, the ratio between the traveling speed at the coagulation bath outlet of the hollow fiber membrane and the winding speed at the end of the spinning process is preferably 1 or more and less than 1.2.
以下、本発明の中空糸膜の効果を実施例を挙げて説明するが、本発明はこれらに限定されるものではない。なお、実施例における物性の評価方法は以下の通りである。 Hereinafter, the effects of the hollow fiber membrane of the present invention will be described with reference to examples, but the present invention is not limited thereto. In addition, the evaluation method of the physical property in an Example is as follows.
(透水性)
透析器の血液出口部回路(圧力測定点よりも出口側)を鉗子で挟んで封止した。37℃に保温した純水を加圧タンクに入れ、レギュレーターにより圧力を制御しながら、37℃恒温槽で保温した透析器の血液流路側へ純水を送り、透析液側から流出した濾液量を測定した。膜間圧力差(TMP)は
TMP=(Pi+Po)/2
とする。ここでPiは透析器入り口側圧力、Poは透析器出口側圧力である。TMPを4点変化させ濾過流量を測定し、それらの関係の傾きから透水性(mL/hr/mmHg)を算出した。このときTMPと濾過流量の相関係数は0.99以上でなければならない。また、回路による圧力損失誤差を少なくするために、TMPは100mmHg以下の範囲で測定する。中空糸膜の透水性は膜面積と透析器の透水性から算出する。
UFR(H)=UFR(D)/A
ここでUFR(H)は中空糸膜の透水性(mL/m2/hr/mmHg)、UFR(D)は透析器の透水性(mL/hr/mmHg)、Aは透析器の膜面積(m2)である。
(Water permeability)
The blood outlet circuit (outlet side from the pressure measurement point) of the dialyzer was sealed with forceps. Purified water kept at 37 ° C is put into a pressurized tank, and while controlling the pressure with a regulator, pure water is sent to the blood flow path side of the dialyzer kept at 37 ° C constant temperature bath, and the amount of filtrate flowing out from the dialysate side is measured. It was measured. The transmembrane pressure difference (TMP) is TMP = (Pi + Po) / 2
And Here, Pi is the dialyzer inlet side pressure, and Po is the dialyzer outlet side pressure. The TMP was changed at four points, the filtration flow rate was measured, and the water permeability (mL / hr / mmHg) was calculated from the slope of the relationship. At this time, the correlation coefficient between TMP and the filtration flow rate must be 0.99 or more. In order to reduce the pressure loss error due to the circuit, TMP is measured in the range of 100 mmHg or less. The water permeability of the hollow fiber membrane is calculated from the membrane area and the water permeability of the dialyzer.
UFR (H) = UFR (D) / A
Here, UFR (H) is the water permeability of the hollow fiber membrane (mL / m 2 / hr / mmHg), UFR (D) is the water permeability of the dialyzer (mL / hr / mmHg), and A is the membrane area of the dialyzer (mL m 2 ).
(中空糸膜の内径、外径、膜厚)
これらの測定は、中空形成材を洗浄、除去した後、中空糸膜を乾燥させた形態で観察する。乾燥方法は問わないが、乾燥により著しく形態が変化する場合には中空形成材を洗浄、除去したのち、純水で完全に置換した後、湿潤状態で形態を観察する。中空糸膜の内径、外径および膜厚は、中空糸膜をスライドグラスの中央に開けられたφ3mmの孔に中空糸膜が抜け落ちない程度に適当本数通し、スライドグラスの上下面でカミソリによりカットし、中空糸膜断面サンプルを得た後、投影機Nikon−V−12Aを用いて中空糸膜断面の短径、長径を測定することにより得られる。中空糸膜断面1個につき2方向の短径、長径を測定し、それぞれの算術平均値を中空糸膜断面1個の内径および外径とし、膜厚は(外径−内径)/2で算出した。5断面について同様に測定を行い、その平均値を内径、外径、膜厚とした。
(Inner diameter, outer diameter, film thickness of hollow fiber membrane)
In these measurements, the hollow forming material is washed and removed, and then the hollow fiber membrane is dried. The drying method is not limited, but when the form changes remarkably by drying, the hollow forming material is washed and removed, then completely replaced with pure water, and then observed in a wet state. The hollow fiber membrane has an inner diameter, an outer diameter, and a film thickness. The hollow fiber membrane is cut through a razor on the top and bottom surfaces of the slide glass so that the hollow fiber membrane does not fall out into a hole of φ3 mm in the center of the slide glass. And after obtaining the hollow fiber membrane cross-section sample, it is obtained by measuring the minor axis and major axis of the hollow fiber membrane cross section using a projector Nikon-V-12A. Measure the short axis and long axis in two directions for each cross section of the hollow fiber membrane, and calculate the arithmetic average value of each of the cross section of the hollow fiber membrane as the inner diameter and outer diameter of one hollow fiber membrane. did. Measurements were similarly made for five cross sections, and the average values were taken as the inner diameter, outer diameter and film thickness.
(平均面粗さ(Ra値))
評価する中空糸膜の外表面を露出させたものを試料とした。原子間力顕微鏡SPI3800(セイコーインスツルメンツ社製)によって形態観察した。この時の観察モードはDFMモード、スキャナーはFS−20A、カンチレバーはDF−3、観測視野は3μm四方である。Ra値は膜表面の凹凸を測定した際の基準点に対する全測定点の凹凸の算術平均を表す。
(Average surface roughness (Ra value))
A sample in which the outer surface of the hollow fiber membrane to be evaluated was exposed was used. The morphology was observed with an atomic force microscope SPI3800 (manufactured by Seiko Instruments Inc.). The observation mode at this time is the DFM mode, the scanner is FS-20A, the cantilever is DF-3, and the observation field is 3 μm square. Ra value represents the arithmetic average of the unevenness | corrugation of all the measurement points with respect to the reference point at the time of measuring the unevenness | corrugation of the film | membrane surface.
(押し出し荷重)
内径3.4cmのポリエチレン製パイプ内に中空糸膜束を充填率47%で充填した測定用サンプルのパイプ外周部を、その形状が変化しないように固定し、直径2.5cm、厚さ0.5cmのテフロン(登録商標)板を先端に取り付けた棒テンションゲージ(大場計器製作所)を用いて、サンプル端部中央部にあて、パイプ内から中空糸膜束を押し出そうとするときの最大荷重を、押し出し荷重(N)とした。本発明において充填率は、下記式に基づいて求める。
充填率(%)=(中空糸膜1本あたりの外径基準断面積×中空糸膜本数)/パイプ内径断面積×100
例えば、中空糸膜の内径が200×10−4cm、膜厚が15×10−4cmの場合、充填率を47%とするためには、47/100×{π×(3.4/2)2}/[π×{(200×10−4+15×10−4×2)/2}2]より、およそ10162〜10379本の中空糸膜が必要である。
(Extruded load)
The outer periphery of a pipe for measurement in which a hollow fiber membrane bundle is filled in a polyethylene pipe having an inner diameter of 3.4 cm at a filling rate of 47% is fixed so that the shape thereof does not change, the diameter is 2.5 cm, the thickness is 0. Maximum load when trying to push out a hollow fiber membrane bundle from the inside of a pipe using a bar tension gauge (Oba Keiki Seisakusho) with a 5cm Teflon (registered trademark) plate attached to the tip. Was the extrusion load (N). In the present invention, the filling rate is obtained based on the following formula.
Filling rate (%) = (outer diameter reference cross section per hollow fiber membrane × number of hollow fiber membranes) / pipe inner diameter cross section × 100
For example, when the hollow fiber membrane has an inner diameter of 200 × 10 −4 cm and a film thickness of 15 × 10 −4 cm, 47/100 × {π × (3.4 / 2) From 2 } / [π × {(200 × 10 −4 + 15 × 10 −4 × 2) / 2} 2 ], approximately 10162 to 10379 hollow fiber membranes are required.
(モジュール作製歩留まり)
ポリエチレン製パイプ内に充填率が47%になるように中空糸膜束を挿入し、これをモジュールケースに挿入する。ポリエチレン製パイプを引き抜いた後、ウレタン樹脂で中空糸膜束とケースを液密に接着する。ウレタン樹脂が硬化した後、中空部が開口するように接着部の一部を切断してモジュールを作製する。このようにして作製した20本のモジュールについて、ケースと中空糸膜の接触部を目視にて観察し、不良糸(折れ、切れ、ねじれ、つぶれ)の有無により、モジュール作製歩留まりを評価する。なお、折れ、ねじれ、つぶれについては、明らかに中空部が閉塞していると思われるものを不良糸と判定し、1本でもそのような中空糸膜が存在すれば不良モジュールとする。本発明を適用することにより、80%以上の合格率を達成することが可能となる。
(Module production yield)
The hollow fiber membrane bundle is inserted into the polyethylene pipe so that the filling rate is 47%, and this is inserted into the module case. After pulling out the polyethylene pipe, the hollow fiber membrane bundle and the case are liquid-tightly bonded with urethane resin. After the urethane resin is cured, a part of the adhesive part is cut so that the hollow part is opened, thereby producing a module. About 20 modules produced in this way, the contact part of a case and a hollow fiber membrane is observed visually, and module production yield is evaluated by the presence or absence of defective yarn (a broken, a piece, a twist, a crush). As for bending, twisting, and crushing, it is determined that a hollow part that is apparently blocked is a defective thread, and if even one such hollow fiber membrane exists, a defective module is obtained. By applying the present invention, it is possible to achieve a pass rate of 80% or more.
(実施例1)
セルローストリアセテート(ダイセル化学社製)19.0質量%、N−メチル−2−ピロリドン(NMP、三菱化学社製)56.7質量%、およびトリエチレングリコール(TEG、三井化学社製)24.3質量%を加熱して均一に溶解し、次いで得られた紡糸原液の脱泡を行った。得られた紡糸原液を孔径10μm、5μmの2段の焼結フィルターに順に通した後、102℃に加温したチューブインオリフィスノズルから中空形成材として予め脱気処理した流動パラフィンとともに同時に吐出し、紡糸管により外気と遮断され、2℃の均一な雰囲気に調整された70mmの乾式部を通過させた後、40℃の20質量%NMP/TEG(7/3)水溶液中で凝固させ、30℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度30m/minで巻き上げた。このとき、紡糸原液の吐出量は0.50ml/min、中空形成材(流動パラフィン)の吐出量は0.96ml/minとした。また、水洗浴は、傾きを2.5度とし、洗浄水が緩やかに下っていくように調整し、洗浄水と中空糸膜とが同一方向に流れる並流とした。水洗浴は5段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.1であった。
Example 1
Cellulose triacetate (manufactured by Daicel Chemical Industries) 19.0% by mass, N-methyl-2-pyrrolidone (NMP, manufactured by Mitsubishi Chemical Corporation) 56.7% by mass, and triethylene glycol (TEG, manufactured by Mitsui Chemicals) 24.3 The mass% was heated and dissolved uniformly, and then the resulting spinning dope was defoamed. The obtained spinning dope is passed through a two-stage sintered filter having a pore diameter of 10 μm and 5 μm in order, and then simultaneously discharged together with liquid paraffin previously degassed as a hollow forming material from a tube-in orifice nozzle heated to 102 ° C., After passing through a 70 mm dry section that is cut off from the outside air by a spinning tube and adjusted to a uniform atmosphere of 2 ° C., it is solidified in a 20 mass% NMP / TEG (7/3) aqueous solution at 40 ° C. After passing through the water washing bath, it was passed through a glycerin bath at 50 ° C. and 60% by mass, dried with a dryer, and wound up at a spinning speed of 30 m / min. At this time, the discharge amount of the spinning solution was 0.50 ml / min, and the discharge amount of the hollow forming material (liquid paraffin) was 0.96 ml / min. In addition, the washing bath was adjusted to have an inclination of 2.5 degrees so that the washing water gradually descended, and the washing water and the hollow fiber membrane flowed in the same direction. The washing bath was 5 steps. The ratio between the traveling speed of the hollow fiber membrane at the coagulation bath outlet and the winding speed at the end of the spinning process was 1.1.
得られた中空糸膜の内径は200.5μm、膜厚は15.8μmであった。得られた中空糸膜を用いて膜面積が1.5m2となるように血液浄化器を作製し評価を行った。結果を表1に示す。 The resulting hollow fiber membrane had an inner diameter of 200.5 μm and a film thickness of 15.8 μm. Using the obtained hollow fiber membrane, a blood purifier was prepared and evaluated so that the membrane area was 1.5 m 2 . The results are shown in Table 1.
(実施例2)
セルローストリアセテート(ダイセル化学社製)19.0質量%、N−メチル−2−ピロリドン(NMP、三菱化学社製)56.7質量%、およびトリエチレングリコール(TEG、三井化学社製)24.3質量%を加熱して均一に溶解し、次いで得られた紡糸原液の脱泡を行った。得られた紡糸原液を孔径10μm、5μmの2段の焼結フィルターに順に通した後、102℃に加温したチューブインオリフィスノズルから中空形成材として予め脱気処理した流動パラフィンとともに同時に吐出し、紡糸管により外気と遮断され、2℃の均一な雰囲気に調整された70mmの乾式部を通過させた後、40℃の20質量%NMP/TEG(7/3)水溶液中で凝固させ、30℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度30m/minで巻き上げた。このとき、紡糸原液の吐出量は0.31ml/min、中空形成材(流動パラフィン)の吐出量は0.55ml/minとした。また、水洗浴は、傾きを2.5度とし、洗浄水が緩やかに下っていくように調整し、洗浄水と中空糸膜とが同一方向に流れる並流とした。水洗浴は5段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.1であった。
(Example 2)
Cellulose triacetate (manufactured by Daicel Chemical Industries) 19.0% by mass, N-methyl-2-pyrrolidone (NMP, manufactured by Mitsubishi Chemical Corporation) 56.7% by mass, and triethylene glycol (TEG, manufactured by Mitsui Chemicals) 24.3 The mass% was heated and dissolved uniformly, and then the resulting spinning dope was defoamed. The obtained spinning dope is passed through a two-stage sintered filter having a pore diameter of 10 μm and 5 μm in order, and then simultaneously discharged together with liquid paraffin previously degassed as a hollow forming material from a tube-in orifice nozzle heated to 102 ° C., After passing through a 70 mm dry section that is cut off from the outside air by a spinning tube and adjusted to a uniform atmosphere of 2 ° C., it is solidified in a 20 mass% NMP / TEG (7/3) aqueous solution at 40 ° C. After passing through the water washing bath, it was passed through a glycerin bath at 50 ° C. and 60% by mass, dried with a dryer, and wound up at a spinning speed of 30 m / min. At this time, the discharging amount of the spinning solution was 0.31 ml / min, and the discharging amount of the hollow forming material (liquid paraffin) was 0.55 ml / min. In addition, the washing bath was adjusted to have an inclination of 2.5 degrees so that the washing water gradually descended, and the washing water and the hollow fiber membrane flowed in the same direction. The washing bath was 5 steps. The ratio between the traveling speed of the hollow fiber membrane at the coagulation bath outlet and the winding speed at the end of the spinning process was 1.1.
得られた中空糸膜の内径は151.2μm、膜厚は12.6μmであった。得られた中空糸膜を用いて膜面積が1.5m2となるように血液浄化器を作製し評価を行った。結果を表1に示す。 The hollow fiber membrane obtained had an inner diameter of 151.2 μm and a film thickness of 12.6 μm. Using the obtained hollow fiber membrane, a blood purifier was prepared and evaluated so that the membrane area was 1.5 m 2 . The results are shown in Table 1.
(実施例3)
セルローストリアセテート(ダイセル化学社製)19.0質量%、N−メチル−2−ピロリドン(NMP、三菱化学社製)56.7質量%、およびトリエチレングリコール(TEG、三井化学社製)24.3質量%を加熱して均一に溶解し、次いで得られた紡糸原液の脱泡を行った。得られた紡糸原液を孔径10μm、5μmの2段の焼結フィルターに順に通した後、102℃に加温したチューブインオリフィスノズルから中空形成材として予め脱気処理した流動パラフィンとともに同時に吐出し、紡糸管により外気と遮断され、2℃の均一な雰囲気に調整された70mmの乾式部を通過させた後、40℃の20質量%NMP/TEG(7/3)水溶液中で凝固させ、30℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度30m/minで巻き上げた。このとき、紡糸原液の吐出量は2.00ml/min、中空形成材(流動パラフィン)の吐出量は1.51ml/minとした。また、水洗浴は、傾きを2.5度とし、洗浄水が緩やかに下っていくように調整し、洗浄水と中空糸膜とが同一方向に流れる並流とした。水洗浴は5段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.1であった。
(Example 3)
Cellulose triacetate (manufactured by Daicel Chemical Industries) 19.0% by mass, N-methyl-2-pyrrolidone (NMP, manufactured by Mitsubishi Chemical Corporation) 56.7% by mass, and triethylene glycol (TEG, manufactured by Mitsui Chemicals) 24.3 The mass% was heated and dissolved uniformly, and then the resulting spinning dope was defoamed. The obtained spinning dope is passed through a two-stage sintered filter having a pore diameter of 10 μm and 5 μm in order, and then simultaneously discharged together with liquid paraffin previously degassed as a hollow forming material from a tube-in orifice nozzle heated to 102 ° C., After passing through a 70 mm dry section that is cut off from the outside air by a spinning tube and adjusted to a uniform atmosphere of 2 ° C., it is solidified in a 20 mass% NMP / TEG (7/3) aqueous solution at 40 ° C. After passing through the water washing bath, it was passed through a glycerin bath at 50 ° C. and 60% by mass, dried with a dryer, and wound up at a spinning speed of 30 m / min. At this time, the discharge amount of the spinning solution was 2.00 ml / min, and the discharge amount of the hollow forming material (liquid paraffin) was 1.51 ml / min. In addition, the washing bath was adjusted to have an inclination of 2.5 degrees so that the washing water gradually descended, and the washing water and the hollow fiber membrane flowed in the same direction. The washing bath was 5 steps. The ratio between the traveling speed of the hollow fiber membrane at the coagulation bath outlet and the winding speed at the end of the spinning process was 1.1.
得られた中空糸膜の内径は250.6μm、膜厚は45.3μmであった。得られた中空糸膜を用いて膜面積が1.5m2となるように血液浄化器を作製し評価を行った。結果を表1に示す。 The resulting hollow fiber membrane had an inner diameter of 250.6 μm and a film thickness of 45.3 μm. Using the obtained hollow fiber membrane, a blood purifier was prepared and evaluated so that the membrane area was 1.5 m 2 . The results are shown in Table 1.
(実施例4)
セルローストリアセテート(ダイセル化学社製)18.0質量%、NMP57.4質量%、およびTEG24.6質量%を均一に溶解し、次いで紡糸原液の脱泡を行った。得られた紡糸原液を孔径10μm、5μmの2段の焼結フィルターに順に通した後、120℃に加温したチューブインオリフィスノズルから中空形成材として予め脱気処理した流動パラフィンとともに同時に吐出し、紡糸管により外気と遮断され、3℃の均一な雰囲気に調整された50mmの乾式部を通過された後、40℃の20質量%NMP/TEG(7/3)水溶液中で凝固させ、30℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度75m/minで巻き上げた。このとき、紡糸原液の吐出量は1.21ml/min、中空形成材(流動パラフィン)の吐出量は2.40ml/minとした。また、水洗浴は、傾きを1度とし、中空糸膜が緩やかに下っていくように調整し、洗浄水と中空糸膜とが同一方向に流れる並流とした。水洗浴は7段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.08であった。
Example 4
Cellulose triacetate (manufactured by Daicel Chemical Industries, Ltd.) 18.0% by mass, NMP 57.4% by mass, and TEG 24.6% by mass were uniformly dissolved, and then the spinning solution was defoamed. The obtained spinning dope is passed through a two-stage sintered filter having a pore size of 10 μm and 5 μm in order, and then simultaneously discharged together with liquid paraffin previously degassed as a hollow forming material from a tube-in orifice nozzle heated to 120 ° C., After being cut off from the outside air by a spinning tube and passed through a 50 mm dry section adjusted to a uniform atmosphere of 3 ° C., it is solidified in an aqueous solution of 20% by mass NMP / TEG (7/3) at 40 ° C. After passing through the water washing bath, it was passed through a glycerin bath at 50 ° C. and 60% by mass, dried with a dryer, and wound up at a spinning speed of 75 m / min. At this time, the discharge amount of the spinning solution was 1.21 ml / min, and the discharge amount of the hollow forming material (liquid paraffin) was 2.40 ml / min. The washing bath was adjusted so that the inclination was 1 degree and the hollow fiber membrane was gently lowered, and the washing water and the hollow fiber membrane were co-flowed in the same direction. The washing bath was 7 steps. The ratio of the hollow fiber membrane running speed at the coagulation bath outlet to the winding speed at the end of the spinning process was 1.08.
得られた中空糸膜の内径は199.8μm、膜厚は15.4μmであった。得られた中空糸膜を用いて実施例1と同様にして評価した。結果を表1に示す。 The resulting hollow fiber membrane had an inner diameter of 199.8 μm and a film thickness of 15.4 μm. Evaluation was conducted in the same manner as in Example 1 using the obtained hollow fiber membrane. The results are shown in Table 1.
(比較例1)
セルローストリアセテート(ダイセル化学社製)19.0質量%、NMP56.7質量%、およびTEG24.3質量%を加熱して均一に溶解し、次いで紡糸原液の脱泡を行った。得られた紡糸原液を孔径20μm、20μmの2段の焼結フィルターに順に通した後、105℃に加温したチューブインオリフィスノズルから中空形成材として予め脱気処理した流動パラフィンとともに同時に吐出し、紡糸管により外気と遮断され、48℃の均一な雰囲気に調整された70mmの乾式部を通過させた後、40℃の20質量%NMP/TEG(7/3)水溶液中で凝固させ、30℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度85m/minで巻き上げた。このとき、紡糸原液の吐出量は1.18ml/min、中空形成材(流動パラフィン)の吐出量は2.40ml/minとした。また、水洗浴は、傾きを0.5度とし、中空糸膜が緩やかに上っていくように調整し、洗浄水と中空糸膜とが逆方向に流れる向流とした。水洗浴は7段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.25であった。
(Comparative Example 1)
Cellulose triacetate (manufactured by Daicel Chemical Industries) 19.0 mass%, NMP 56.7 mass%, and TEG 24.3 mass% were heated and dissolved uniformly, and then the spinning dope was defoamed. The obtained spinning dope is passed through a two-stage sintered filter having a pore diameter of 20 μm and 20 μm in order, and then simultaneously discharged together with liquid paraffin previously deaerated as a hollow forming material from a tube-in orifice nozzle heated to 105 ° C., After passing through a 70 mm dry section that was cut off from the outside air by a spinning tube and adjusted to a uniform atmosphere of 48 ° C., it was coagulated in an aqueous solution of 20 mass% NMP / TEG (7/3) at 40 ° C., and 30 ° C. After passing through the water washing bath, it was passed through a glycerin bath at 50 ° C. and 60% by mass, dried with a dryer, and wound up at a spinning speed of 85 m / min. At this time, the discharge amount of the spinning solution was 1.18 ml / min, and the discharge amount of the hollow forming material (liquid paraffin) was 2.40 ml / min. Further, the washing bath was adjusted so that the inclination was 0.5 degree and the hollow fiber membrane was gently raised, and the washing water and the hollow fiber membrane were counterflowed in opposite directions. The washing bath was 7 steps. The ratio of the hollow fiber membrane running speed at the coagulation bath outlet to the winding speed at the end of the spinning process was 1.25.
得られた中空糸膜の内径は199.8μm、膜厚は15.0μmであった。得られた中空糸膜を用いて実施例1と同様にして評価した。結果を表1に示す。 The resulting hollow fiber membrane had an inner diameter of 199.8 μm and a film thickness of 15.0 μm. Evaluation was conducted in the same manner as in Example 1 using the obtained hollow fiber membrane. The results are shown in Table 1.
(比較例2)
ポリエーテルスルホン(住友化学社製 高重合度ポリエーテルスルホン7300P)16.0質量%、ポリビニルピロリドン(BASF社製 PVP K−90)6.0質量%、N−メチル−2−ピロリドン(NMP、三菱化学社製)46.8質量%、およびポリエチレングリコール(PEG200、第一工業製薬製)31.2質量%を加熱して均一に溶解し、次いで紡糸原液の脱泡を行った。得られた紡糸原液を孔径10μm、5μmの2段の焼結フィルターに順に通した後、80℃に加温したチューブインオリフィスノズルから中空形成材としてN−メチル−2−ピロリドン(NMP、三菱化学社製)36質量%およびポリエチレングリコール(PEG200、第一工業製薬製)24質量%、および水40質量%とともに同時に吐出し、紡糸管により外気と遮断され、43℃の均一な雰囲気に調整された8mmの乾式部を通過させた後、40℃の40質量%NMP/PEG200(6/4)水溶液中で凝固させ、50℃の水洗浴を経た後、50℃、60質量%のグリセリン浴に通過させ、ドライヤーで乾燥し、紡糸速度30m/minで巻き上げた。このとき、紡糸原液の吐出量は0.65ml/min、中空形成材(水系内液)の吐出量は0.97ml/minとした。また、水洗浴は、傾きを0.5度とし、中空糸膜が緩やかに上っていくように調整し、洗浄水と中空糸膜とが逆方向に流れる向流とした。水洗浴は7段とした。凝固浴出口の中空糸膜走行速度と、紡糸工程最後の巻き取り速度との比は、1.25であった。
(Comparative Example 2)
Polyethersulfone (Sumitomo Chemical High Polymerization Polyethersulfone 7300P) 16.0% by mass, Polyvinylpyrrolidone (BASF PVP K-90) 6.0% by mass, N-methyl-2-pyrrolidone (NMP, Mitsubishi (Chemical Co., Ltd.) 46.8% by mass and polyethylene glycol (PEG200, manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) 31.2% by mass were heated and dissolved uniformly, and then the spinning solution was defoamed. The obtained spinning dope was passed through a two-stage sintered filter having a pore size of 10 μm and 5 μm in order, and then N-methyl-2-pyrrolidone (NMP, Mitsubishi Chemical) was used as a hollow forming material from a tube-in orifice nozzle heated to 80 ° C. Co., Ltd.) 36% by mass, polyethylene glycol (PEG200, manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) 24% by mass, and water 40% by mass were discharged simultaneously, blocked from the outside by a spinning tube, and adjusted to a uniform atmosphere of 43 ° C. After passing through an 8 mm dry section, it is solidified in a 40% by mass NMP / PEG200 (6/4) aqueous solution at 40 ° C., passed through a 50 ° C. water washing bath, and then passed through a 50 ° C., 60% by mass glycerin bath. And dried with a dryer and wound up at a spinning speed of 30 m / min. At this time, the discharge amount of the spinning solution was 0.65 ml / min, and the discharge amount of the hollow forming material (aqueous system liquid) was 0.97 ml / min. Further, the washing bath was adjusted so that the inclination was 0.5 degree and the hollow fiber membrane was gently raised, and the washing water and the hollow fiber membrane were counterflowed in opposite directions. The washing bath was 7 steps. The ratio of the hollow fiber membrane running speed at the coagulation bath outlet to the winding speed at the end of the spinning process was 1.25.
得られた中空糸膜の内径は201.2μm、膜厚は20.0μmであった。得られた中空糸膜を用いて実施例1と同様にして評価した。結果を表1に示す。 The obtained hollow fiber membrane had an inner diameter of 201.2 μm and a film thickness of 20.0 μm. Evaluation was conducted in the same manner as in Example 1 using the obtained hollow fiber membrane. The results are shown in Table 1.
表1から明らかなように、Ra値が10nm以下の実施例1〜4は、押し出し荷重が低く、モジュール作製の歩留まりが良好である。特にRa値が低い実施例2,4は結果が極めて良好である。これに対して、Ra値が10nmを越える比較例1,2は、押し出し荷重が高く、結果としてモジュール作製歩留まりが悪い。 As is apparent from Table 1, Examples 1 to 4 having an Ra value of 10 nm or less have a low extrusion load and a good module production yield. In particular, the results of Examples 2 and 4 having a low Ra value are very good. On the other hand, Comparative Examples 1 and 2 with an Ra value exceeding 10 nm have a high extrusion load, resulting in a poor module production yield.
本発明の血液浄化用中空糸膜は、外表面の平均面粗さを低くすることによりモジュール組み立て時の作製歩留まりを高い水準で維持することができる。従って、本発明の血液浄化用中空糸膜は、経済的にかつ安定して製造することができるという利点を有する。 The hollow fiber membrane for blood purification of the present invention can maintain the production yield at the time of module assembly at a high level by reducing the average surface roughness of the outer surface. Therefore, the hollow fiber membrane for blood purification of the present invention has an advantage that it can be produced economically and stably.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009171916A JP2011024708A (en) | 2009-07-23 | 2009-07-23 | Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009171916A JP2011024708A (en) | 2009-07-23 | 2009-07-23 | Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011024708A true JP2011024708A (en) | 2011-02-10 |
Family
ID=43634179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009171916A Pending JP2011024708A (en) | 2009-07-23 | 2009-07-23 | Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011024708A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3915776A4 (en) * | 2019-01-21 | 2022-11-02 | Nitto Denko Corporation | Film |
| EP4335539A3 (en) * | 2014-03-29 | 2024-05-01 | Princeton Trade and Technology Inc. | Blood processing cartridges and systems, and methods for extracorporeal blood therapies |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008073134A (en) * | 2006-09-20 | 2008-04-03 | Toyobo Co Ltd | Hollow fiber membrane for blood purification, and method for producing the same |
| WO2008046779A1 (en) * | 2006-10-18 | 2008-04-24 | Gambro Lundia Ab | Hollow fiber membrane and method for manufacturing thereof |
| JP2008207153A (en) * | 2007-02-28 | 2008-09-11 | Toray Ind Inc | Hollow-fiber membrane and hollow-fiber membrane module |
| JP2008284186A (en) * | 2007-05-18 | 2008-11-27 | Toyobo Co Ltd | Porous hollow-fiber membrane with superior stable permeability |
| JP2009136866A (en) * | 2007-11-14 | 2009-06-25 | Toray Ind Inc | Case for hollow fiber membrane module, hollow fiber membrane module, and its manufacturing method |
-
2009
- 2009-07-23 JP JP2009171916A patent/JP2011024708A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008073134A (en) * | 2006-09-20 | 2008-04-03 | Toyobo Co Ltd | Hollow fiber membrane for blood purification, and method for producing the same |
| WO2008046779A1 (en) * | 2006-10-18 | 2008-04-24 | Gambro Lundia Ab | Hollow fiber membrane and method for manufacturing thereof |
| JP2008207153A (en) * | 2007-02-28 | 2008-09-11 | Toray Ind Inc | Hollow-fiber membrane and hollow-fiber membrane module |
| JP2008284186A (en) * | 2007-05-18 | 2008-11-27 | Toyobo Co Ltd | Porous hollow-fiber membrane with superior stable permeability |
| JP2009136866A (en) * | 2007-11-14 | 2009-06-25 | Toray Ind Inc | Case for hollow fiber membrane module, hollow fiber membrane module, and its manufacturing method |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4335539A3 (en) * | 2014-03-29 | 2024-05-01 | Princeton Trade and Technology Inc. | Blood processing cartridges and systems, and methods for extracorporeal blood therapies |
| EP3915776A4 (en) * | 2019-01-21 | 2022-11-02 | Nitto Denko Corporation | Film |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5218044B2 (en) | Hollow fiber membrane excellent in performance stability, blood purifier, and method for producing hollow fiber membrane | |
| JP5720249B2 (en) | Hollow fiber membrane, method for producing the same, and blood purification module | |
| JP5440332B2 (en) | Hollow fiber membrane | |
| JPH10108907A (en) | Membrane for hemocatharsis, its preparation and module for hemocatharsis | |
| JP5217238B2 (en) | Porous hollow fiber membrane and blood purifier excellent in permeation performance stability | |
| JP4940576B2 (en) | Hollow fiber membrane and blood purifier | |
| JP2008237987A (en) | Manufacturing method of hollow fiber membrane and hollow fiber membrane | |
| JP5136909B2 (en) | Method for producing hollow fiber membrane | |
| JP5292762B2 (en) | Blood purifier with excellent mass replacement characteristics | |
| JP6699751B2 (en) | Cellulose acetate hollow fiber membrane | |
| JP2011024708A (en) | Hollow fiber membrane for blood purification which is excellent in workability for module assembly, and method for manufacturing the same | |
| JP2008246402A (en) | Hollow fiber type blood purification membrane and method of manufacturing the same | |
| JP6699750B2 (en) | Cellulose acetate-based asymmetric hollow fiber membrane | |
| JP4923902B2 (en) | Hollow fiber membrane for blood purification and method for producing the same | |
| JP2009125650A (en) | Porous hollow fiber membrane and method for producing the same, and hollow fiber membrane module | |
| JP2010063605A (en) | Blood purifier having excellent impact resistance | |
| JP4093134B2 (en) | Hollow fiber blood purification membrane | |
| JP5578210B2 (en) | Method for producing porous hollow fiber membrane | |
| JP5423326B2 (en) | Method for producing hollow fiber membrane | |
| JP6707880B2 (en) | Hollow fiber membrane and hollow fiber membrane module | |
| JP5614470B2 (en) | Blood purifier with excellent mass replacement characteristics | |
| JP2010111965A (en) | Blood purifier having excellent impact resistance | |
| JP2011020071A (en) | Method for manufacturing polysulfone-based hollow fiber membrane | |
| JP2005021510A (en) | Highly permeabile hollow fiber type hemocatharsis device | |
| JP5299617B2 (en) | Method for producing hollow fiber membrane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120403 |
|
| A977 | Report on retrieval |
Effective date: 20130726 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130730 |
|
| A521 | Written amendment |
Effective date: 20130919 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131126 |